<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Sch of Life Sciences</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0FEA323B-5383-4C1C-A72E-0D58CEA05208"><gtr:id>0FEA323B-5383-4C1C-A72E-0D58CEA05208</gtr:id><gtr:firstName>Majid</gtr:firstName><gtr:surname>Hafezparast</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300854"><gtr:id>5BC82EC1-79AA-4E0B-9E9F-04FFFDBF68E7</gtr:id><gtr:title>Pathfinder: Investigation into the link between defective axonal transport and motor neuron disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300854</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>154219</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Patient-carer conference</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5E302414-DEC7-4A04-97C5-D5E7679E9E7E</gtr:id><gtr:impact>Ipresentd our data at the annual ALS/MND symposia, attended by scientists as well as patients and their carers, providing us with the opportunity to communicate our results with the public. I also took part in the May 2008 MNDA Spring Conference as an expert to inform the patients and their carers about our research and answer questions about the current advances in ALS research.

The importance of the use animals in research into the causes of motor neuron disease and in developing novel therapeutic approaches for this disease was highlighted.</gtr:impact><gtr:outcomeId>F32D89FFB89</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated induced pluripotent stem cells (IPSCs) from fibroblasts isolated from two mouse strains harbouring single mutations in the gene encoding cytoplasmic dynein heavy chain (DYNC1H1). We have also set up the differentiation of these cells into motor neurons.</gtr:description><gtr:id>C4BD9445-91BE-45A3-B27C-4F8D13AFD3B7</gtr:id><gtr:impact>The establishment of this technique in my group has opened up the possibility of generation of IPSCs from human patients who have mutation in DYNC1H1, which causes a form of motor neurone disease (and in some cases combined with intellectual disability). Therefore, we will be able to examine the underlying molecular mechanisms of the disease at the cellular level.</gtr:impact><gtr:outcomeId>mL1x7UoYXwk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Induced pluripotent stem cells from cytoplasmic dynein mutant mice</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D797C941-E0D0-4546-A959-3C4651097F6A</gtr:id><gtr:title>A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c84259394e7741d0d16666d2efedf078"><gtr:id>c84259394e7741d0d16666d2efedf078</gtr:id><gtr:otherNames>Kieran D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>4120628498E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D16DCCFD-8356-45F7-BA88-F77205533DF9</gtr:id><gtr:title>Binding of dynein intermediate chain 2 to paxillin controls focal adhesion dynamics and migration.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4612d32fc4cb17669eaf2e15194f5eb3"><gtr:id>4612d32fc4cb17669eaf2e15194f5eb3</gtr:id><gtr:otherNames>Rosse C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14166_26_22553211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F38F87B-7BCD-4E8C-9046-858257A1521B</gtr:id><gtr:title>The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e78549a28b33ad69cc45ce2d814a8585"><gtr:id>e78549a28b33ad69cc45ce2d814a8585</gtr:id><gtr:otherNames>Achilli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1466-0822</gtr:issn><gtr:outcomeId>7BCA7CEEA3E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD50EC2E-ECDC-4F83-9ACE-9A11ABD8266D</gtr:id><gtr:title>Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a45e1c8bd416ccf58b3bb9cd237ae7c2"><gtr:id>a45e1c8bd416ccf58b3bb9cd237ae7c2</gtr:id><gtr:otherNames>Eschbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_14166_26_20887786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9797DE72-8580-4C4D-AE31-37BFB7018D01</gtr:id><gtr:title>Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d0493aca288feb1c7b928115cc28a"><gtr:id>a19d0493aca288feb1c7b928115cc28a</gtr:id><gtr:otherNames>De Vos KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>58b603b8ecada9.83011975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10318343-5451-4312-9140-695ED487D5B0</gtr:id><gtr:title>Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3399b1ce77e497785d216c261ec6f6d7"><gtr:id>3399b1ce77e497785d216c261ec6f6d7</gtr:id><gtr:otherNames>Kuta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_53d080080da52261</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300854</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>